Analysis by Offering (Software and Services), Deployment (On-Premises and Cloud), Organization Size (SMEs and Large Enterprises), and Application (Pharmaceutical, Biotechnology, and Medical Devices)
No. of Pages:118
Report Code:
BMIRE00028430
Category:
Technology, Media and Telecommunications
South America Manufacturing Execution System (MES) In Life Sciences Market
The South America manufacturing execution system in life sciences market is expected to grow from US$ 191.40 million in 2023 to US$ 539.98 million by 2033. It is estimated to grow at a CAGR of 10.9% from 2023 to 2033.
Rise in Adoption of Pharma 4.0 Fuels South America Manufacturing Execution System (MES) In Life Sciences Market
The growing digitization in the pharmaceutical industry is raising the demand for Pharma 4.0. The model helps increase connectivity and productivity, simplify compliance, and marshal production information to respond to problems as they emerge. The Pharma 4.0 model helps transform the manufacturing workforce by connecting workers to more human-centric workflows by shifting the company culture. Various regulatory bodies, such as International Society for Pharmaceutical Engineering (ISPE) and its members, are developing a roadmap to introduce Pharma 4.0. The objective of the Pharma 4.0 model is to enable organizations to leverage the full potential of digitalization to provide faster therapeutic innovations and improve production processes for the patient's benefit. Pharma 4.0 allows organizations to connect teams, uphold compliance standards and provide deep analytics, enhancing safety, yield, and quality. Thus, Pharma 4.0 helps provide real-time data and predictive analysis to optimize production, improve quality assurance and regulatory compliance, reduce risk, and enhances business. MES is a crucial element of Pharma 4.0 as it links machines and systems together to create intelligent networks that control each other, ensure better process flow, and can be programmed to trigger automatic processes as needed. Intelligent MES and EBR are being developed, specifically for smaller factories and plants, to promote the adoption of Pharma 4.0 among such stakeholders. Key players of the Pharma 4.0 ecosystem are collaborating to accelerate the adoption of the same. For instance, in March 2021, Lonza and NNIT announced a partnership to speed up MES projects. Under this partnership, the companies will combine Lonza’s MODA Platform with NNIT’s Accelerated Implementation Methodology. Thus, with this, the companies will get a complete pharma 4.0 solution and achieve their digitalization vision faster than ever. Therefore, all the above factors are increasing the adoption of Pharma 4.0, fueling the growth of the manufacturing execution system in life sciences market.
South America Manufacturing Execution System (MES) In Life Sciences Market Overview
South America manufacturing execution system market is segmented into Brazil, Argentina, and the Rest of South America. Various vendors can attract new customers and expand their footprint in emerging markets of South America with new technological advancements. At present, South America accounts for ~3% share of the global pharmaceutical industry. The pharmaceutical industry in the region grew at an annual rate of ~7% through 2023. Brazil alone holds the largest share of this industry. The pharmaceutical manufacturing industry in the country has positioned itself to serve other emerging South American markets as well.
South America Manufacturing Execution System (MES) In Life Sciences Market Revenue and Forecast to 2033 (US$ Million)
South America Manufacturing Execution System (MES) In Life Sciences Market Segmentation
Based on offering, the South America manufacturing execution system in life sciences market is segmented into software and services. The services segment held a larger share of the South America manufacturing execution system in life sciences market in 2023.
Based on deployment, the South America manufacturing execution system in life sciences market is segmented into on-premises and cloud. The cloud segment held a larger share of the South America manufacturing execution system in life sciences market in 2023.
Based on organization size, the South America manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. The large enterprises segment held the largest share of the South America manufacturing execution system in life sciences market in 2023.
Based on application, the South America manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices. The medical devices segment held the largest share of the South America manufacturing execution system in life sciences market in 2023.
Based on country, the South America manufacturing execution system in life sciences market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the share of the South America manufacturing execution system in life sciences market in 2023.
Emerson Electric Co; Rockwell Automation Inc; Schneider Electric SE; and Siemens AG are the leading companies operating in the South America manufacturing execution system in life sciences market.
South America Manufacturing Execution System (MES) In Life Sciences Market Strategic Insights
Get more information on this report
South America Manufacturing Execution System (MES) In Life Sciences Market Segmentation Analysis
South America Manufacturing Execution System (MES) In Life Sciences Market Report Highlights
South America Manufacturing Execution System (MES) In Life Sciences Report Scope
Report Attribute
Details
Market size in 2023
US$ 191.40 Million
Market Size by 2033
US$ 539.98 Million
CAGR (2023 - 2033)
10.9%
Historical Data
2021-2022
Forecast period
2024-2033
Segments Covered
By Offering
Software
Services
By Deployment
On-Premises
Cloud
By Organization Size
SMEs
Large Enterprises
By Application
Pharmaceutical
Biotechnology
Medical Devices
Regions and Countries Covered
South and Central America
Brazil, Argentina, Rest of South and Central America
Market leaders and key company profiles
Emerson Electric Co
Rockwell Automation Inc
Schneider Electric SE
Siemens AG
Get more information on this report
South America Manufacturing Execution System (MES) In Life Sciences Market Country and Regional Insights
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - South America Manufacturing Execution System (MES) In Life Sciences Market
Emerson Electric Co
Rockwell Automation Inc
Schneider Electric SE
Siemens AG
Frequently Asked Questions
How big is the South America Manufacturing Execution System (MES) In Life Sciences Market?
The South America Manufacturing Execution System (MES) In Life Sciences Market is valued at US$ 191.40 Million in 2023, it is projected to reach US$ 539.98 Million by 2033.
What is the CAGR for South America Manufacturing Execution System (MES) In Life Sciences Market by (2023 - 2033)?
As per our report South America Manufacturing Execution System (MES) In Life Sciences Market, the market size is valued at US$ 191.40 Million in 2023, projecting it to reach US$ 539.98 Million by 2033. This translates to a CAGR of approximately 10.9% during the forecast period.
What segments are covered in this report?
The South America Manufacturing Execution System (MES) In Life Sciences Market report typically cover these key segments-
Offering (Software, Services)
Deployment (On-Premises, Cloud)
Organization Size (SMEs, Large Enterprises)
Application (Pharmaceutical, Biotechnology, Medical Devices)
What is the historic period, base year, and forecast period taken for South America Manufacturing Execution System (MES) In Life Sciences Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Manufacturing Execution System (MES) In Life Sciences Market report:
Historic Period : 2021-2022
Base Year : 2023
Forecast Period : 2024-2033
Who are the major players in South America Manufacturing Execution System (MES) In Life Sciences Market?
The South America Manufacturing Execution System (MES) In Life Sciences Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Emerson Electric Co
Rockwell Automation Inc
Schneider Electric SE
Siemens AG
Who should buy this report?
The South America Manufacturing Execution System (MES) In Life Sciences Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the South America Manufacturing Execution System (MES) In Life Sciences Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For South America Manufacturing Execution System (MES) In Life Sciences Market
